(26-09-2015, 09:34 PM)bobie Wrote: I dont think the figures where correct anyway, what i mean is they may have said progesterone but all the figures where to do with progestins which yes did increase the risk of cancer slightly but it was either not increased or was marginal when it came to bio identical progesterone so it was a bit biased, not helped by the fact that these two didnt like progesterone either.
(26-09-2015, 09:34 PM)bobie Wrote: Interesting, i used to eat a peanut butter sandwich every evening before my diet, now its just occasionally, may have one this evening in fact
Is that just greek yoghurt or any yogurt? i ear a muller corner each day but was never keen on plain yoghurt
(26-09-2015, 09:34 PM)bobie Wrote: I have been trying to raise growth hormone through adding certain foods to my diet, my understanding is oral estrogens also lower growth hormone, i need to look into HIIT exercises then, are there any legit safe supplements that actually raise growth hormone?
(23-07-2015, 03:37 AM)Lotus Wrote: Viitamin D (D3) is underestimated for NBE. Not only is it an aromatase, it will increase E2 synthesis, and get rid of visceral fat.
This (D3) clears off the shelf of about 3-4 NBE products and keeps money in your pocket, how cool is that?.
____________________
We conclude that 1,25-dihydroxyvitamin D3 directly regulates adipocyte 11beta-HSD 1 expression and, consequently, local cortisol levels and that this may contribute to the preferential loss of visceral adiposity by high- calcium diets.
1,25-Dihydroxyvitamin D3 Modulation of Adipocyte Glucocorticoid Function
http://onlinelibrary.wiley.com/store/10.1038/oby.2005.75/asset/oby.2005.75.pdf?v=1&t=icfkstuw&s=b5a9d9b5caa4998c3c65827467cc842bb9dda82a
(08-06-2015, 11:34 PM)Lotus Wrote: vitamin D analogs significantly upregulated E2- and DHT-induced CK response. These analogs upregulated the CK response to selective estrogen receptor modulators (SERMs). An estrogenic response (from vitamin D) is seen in the intestinal tract. Vitamin D also helps with hair growth.
http://www.howtomakeyourhairgrowfast.net/does-vitamin-d-help-hair-growth.html
Interaction Between Estrogen and Vitamin D–Endocrine System: A Potential Addition to the Unitary Model of Osteoporosis
http://onlinelibrary.wiley.com/doi/10.1359/jbmr.1998.13.12.1954/full
Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo.
Somjen D1.
Author information
Abstract
Vitamin D analogs modulate different organs, including modulation of energy metabolism, through the induction of creatine kinase (CK) activity. Skeletal organs from vitamin D-depleted rats showed lower constituent CK than those from vitamin D-replete rats. Moreover, estradiol-17beta (E2) or dihydrotestosterone (DHT), which increased CK in organs from intact female or male rats, respectively, stimulated much less CK in vitamin D-depleted rats. Treatment of intact female rats with noncalcemic vitamin D analogs significantly upregulated E2- and DHT-induced CKresponse. These analogs upregulated the CK response to selective estrogen receptor modulators (SERMs) in organs from intact or ovariectomized (Ovx) female rats but abolished SERMs' inhibitory effect on E2-induced CK. These analogs significantly increased estradiol receptor alpha (ERalpha) protein in skeletal organs as well as histomorphological and biochemical changes due to this treatment followed by E2 or DHT. The analogs alone markedly altered the growth plate and the trabeculae and increased trabecular bone volume (%TB V) and trabecular width. The addition of E2 or DHT to this treatment restored all parameters as well as increased %TBV and cell proliferation. Treatment of Ovx female rats with JK 1624 F2-2 (JKF) decreased growth-plate width and increased %TB V, whereas QW1624 F2-2 (QW) restored growth-plate width and %TB V. Treatment of E2 with JKF restored %TBV and growth-plate width, whereas E2 with QW restored all parameters, including cortical width. There was also upregulation of the response of CK to E2 in both combined treatments. Our human-derived osteoblast (hObs)-like cell cultures respond to estrogenic compounds, and pretreating them with JKF upregulated the CK response to E2, raloxifene (Ral), and some phytoestrogens. ERalpha and ERbeta proteins, as well as mRNA, were modulated by CB 1093 (CB) and JKF. JKF increased specific nuclear E2 binding in female hObs but inhibited specific membranal E2 binding. hObs express 25 hydroxyvitamin D3-1alpha hydroxylase (1-OHase)-mRNA and its biological activity, which are both modulated by parathyroid hormone (PTH) and estrogenic compounds. Our results demonstrate mutual interaction between vitamin D and estrogenic compounds. We therefore conclude that combined treatment with less-calcemic analogs of vitamin D and estrogenic compounds might be superior for treatment of bone damage caused by ovariectomy in female rats, with possible application for postmenopausal osteoporosis.
PMID: 17725484 [PubMed - indexed for MEDLINE]
http://www.ncbi.nlm.nih.gov/pubmed/17725484
(22-10-2015, 03:05 PM)bobie Wrote: Finally got round to doing those blood tests, here are the results:
Estradiol 298 pmol (81pg/ml)
Testosterone 0.6 nmol/l (17 ng/dl)
Free androgen index 0.6%
SHBG 103.6 nmol/l
LH 0.4 iu/l
FSH 0.4 iu/l
Prolactin 593 miu/l, high but im pleased with this as its come down, it was nearly 700 m
iu/l the two previous times tested
Any imput as always would be greatly appreciated lotus, im really going to miss you when you go, any chance of being able to keep in touch by email?
(25-10-2015, 08:44 PM)bobie Wrote: Thanks lotus, so if levels are alright whats the cause of not much happening in the boob department? just a slow developer or do i need more e2? sure i have boobs (36" underbust, 39" bust) but when i lay down theres no projection so i dont think theres a lot happening with the glandular tissue, if you do write a thesis on fsh i would be very interested in seeing it, could you please pm me your email address, thanks